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Abstract (150/150 words) 
INTRODUCTION: To understand the potential influence of diversity on the measurement of functional 
impairment in dementia, we aimed to investigate possible bias caused by age, gender, education, and 
cultural differences. 
METHODS: 3,571 individuals (67.1 ± 9.5 years old, 44.7% female) from the Netherlands, Spain, France, 
United States, United Kingdom, Greece, Serbia and Finland were included. Functional impairment was 
measured using the Amsterdam IADL Questionnaire. Item bias was assessed using differential item 
functioning (DIF) analysis. 
RESULTS: There were some differences in activity endorsement. A few items showed statistically 
significant DIF. However, there was no evidence of meaningful item bias: effect sizes were low (ΔR2 
range 0–0.03). Impact on total scores was minimal. 
DISCUSSION: The results imply a limited bias for age, gender, education and culture in the 
measurement of functional impairment. This study provides an important step in recognizing the 
potential influence of diversity on primary outcomes in dementia research. 
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1. Introduction 
Impairment in cognitively complex ‘instrumental activities of daily living’ (IADL), such as doing grocery 
shopping, managing personal finances and using mobile devices, may be one of the first symptoms of 
dementia [1-3]. IADL performance is related to quality of life, caregiver burden and resource utilization 
[4]. Moreover, IADL impairment in preclinical stages might be a predictor of progression to dementia 
[5, 6]. Therefore, functional impairment is an important and highly relevant outcome measure for 
clinical practice and clinical trials. In recently drafted industry guidelines, the U.S. Food and Drug 
Administration recommended the use of functional impairment as a measure for effectiveness of 
treatment and of disease progression [7]. It is a potential global outcome measure in dementia 
research [8, 9]. 
 
Because everyday functioning relates to daily life, IADL may be especially sensitive to bias caused by 
various factors, such as age, gender, and cultural differences. Previous studies have shown gender 
effects on traditional IADL instruments [9-12], as they predominantly include household activities, 
which may be performed more often by women. Scientific literature concerning cultural and 
ethnoracial diversity in the context of dementia is scarce [13, 14]. The selection of activities to include 
in an IADL instrument may be culture-specific. For example, in the United States it is customary to 
write checks, whereas in the Netherlands, people often use online banking. Mere translation of an 
instrument does not always account for national (cross-cultural) disparities [15, 16], and while many 
functional instruments have been translated into numerous languages, there is no gold standard for 
cross-cultural adaptation of questionnaires [17]. This emphasizes the importance of investigating 
potential sources of bias and their influence on item and scale level. 
 
We aimed to study potential influences of diversity on the measurement of functional impairment 
using the Amsterdam IADL Questionnaire (A-IADL-Q). Specifically, we investigated item bias caused by 
various factors: cross-cultural differences (operationalized by using country of residence), age, gender, 
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and education. We obtained data from eight Western countries: The Netherlands, Spain, France, 
United States, United Kingdom, Greece, Serbia, and Finland. 
  
Page 6 of 25 
 
2. Methods 
The present study included data from 3,571 individuals with a completed A-IADL-Q from memory 
clinics and cognition studies from eight countries: the Netherlands (Amsterdam Dementia Cohort [18] 
and European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study, EPAD [19, 20]), Spain 
(Compostela Aging Study [21, 22]; EPAD; and ALFA project [23]), France (INSIGHT pre-AD [24]; EPAD; 
and Socrates study), United States (Butler Alzheimer’s Prevention Registry [25]), United Kingdom 
(EPAD and SAMS project [26]), Greece (Greek Association for Alzheimer’s Disease and Related 
Disorders), Serbia (Niš Clinic of Neurology [27]), and Finland (Helsinki Small Vessel Disease study). 
 
Participants had some degree of cognitive complaints, or had an increased genetic or neurovascular 
risk for cognitive decline. Participants were recruited from memory clinics, through advertisement, or 
from existing databanks. Inclusion criteria ranged from being cognitively normal to having a dementia-
related diagnosis. Other relevant inclusion and exclusion criteria for each cohort in this study can be 
found in Table 1. Participants provided written informed consent, and the studies were approved by 
their institutional review boards, which included, in each, consent for data sharing.
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Table 1 
Information about participants, in- and exclusion criteria, and information about the A-IADL-Q administration per included sample 
Study name 
Amsterdam 
Dementia Cohort 
[18] 
Compostela Aging 
Study [21, 22] 
European Prevention 
of Alzheimer's 
Dementia 
Longitudinal Cohort 
Study (EPAD) [19, 20] 
ALFA+ Study [23] INSIGHT preAD [24] 
Butler Alzheimer's 
Prevention Registry 
[25] 
SOCRATES 
Greek Association of 
Alzheimer's Disease 
and Related 
Disorders 
Niš Clinic of 
Neurology [27] 
Helsinki Small Vessel 
Disease study 
SAMS Project [26] 
Country Netherlands Spain Spain (n = 218) 
France (n = 103) 
Netherlands (n = 88) 
United Kingdom (n = 
71) 
Spain France United States of 
America 
France Greece Serbia Finland United Kingdom 
Participants 
included 
1,429 600 480 333 308 154 98 61 45 43 22 
Age range 25–84 years 50–101 years 51–88 years 49–73 years 70–85 years 58–77 years 46–85 years 65–92 years 26–93 years 66–75 years 65–82 years 
Research 
environment 
           
Recruitment Consecutive memory 
clinic patients 
MCI patients referred 
by GP 
Participants from 
existing study cohorts 
Mostly offspring of 
AD patients 
Consecutive memory 
clinic patients & 
advertisement 
recruited 
Advertisement 
recruited 
Memory clinic 
patients 
Patients from day 
center for dementia 
Memory clinic 
patients 
Patients with 
neuroimaging data 
selected from existing 
databank 
Recruited from 
dementia research 
registry, memory 
clinic patients 
Relevant 
inclusion and 
exclusion criteria 
None Cognitive complaints 
without dementia; 
Age ≥ 50 years 
No dementia; 
Age ≥ 50 years 
CN (MMSE ≥ 26, CDR 
0); 
No neurological 
diseases; 
Age 45–74 years 
CN (MMSE ≥ 27, CDR 
0); 
Amyloid PET at 
baseline; 
No episodic memory 
deficits, no 
neurological diseases; 
Not living in nursing 
home; 
Age 70–85 years 
CN or mild memory 
loss; 
No neurological 
diseases or dementia 
diagnosis; 
Age 55–85 years 
Dementia-related 
diagnosis (MMSE ≥ 
10); 
No neurological 
diseases other than 
dementia; 
Age 40–85 years 
Dementia-related 
diagnosis; 
Reliable informant; 
No neurological 
diseases other than 
dementia; 
Age ≥ 65 years 
CN, MCI, post-stroke 
cognitive impairment 
No major 
neurological 
symptoms or 
psychiatric disease; 
Independence in 
basic ADL; 
No large infarcts, 
hemorrhages, 
contusion or tumor 
on MRI; 
Age 65–75 years 
SCD (ECog ≥ 1.436 
and answered “yes” 
when asked if 
“concerned they 
have a memory or 
other thinking 
problem”), MCI; 
Age ≥ 65 years 
A-IADL-Q version Original (n = 730) 
SV (n = 699) 
Original Original SV Original SV SV Original (n = 28) 
SV (n = 33) 
SV SV Version adapted from 
original 
Clinical measures 
           
Participants (%) 
selected for 
validation* 
1,369 (95.8) 300 (50.0) 480 (100.0) 333 (100.0) 308 (100.0) 154 (100.0) — 26 (42.6) 45 (100.0) 43 (100.0) 22 (100.0) 
Measures 
available 
MMSE, CAMCOG, 
CDR, GDS 
MMSE, CAMCOG, 
GDS 
MMSE, CDR, GDS MMSE, CDR MMSE, CDR MMSE, GDS None MMSE, CAMCOG, 
CDR, GDS 
MMSE MMSE, GDS GDS 
* Participants living in a nursing home were excluded from validation and no clinical measures were obtained for them. 
Additional inclusion and exclusion criteria are available upon request. 
Abbreviations: MCI mild cognitive impairment; GP general practitioner; AD Alzheimer's disease; CN cognitively normal; MMSE Mini-Mental State Examination; CDR Clinical Dementia Rating; ADL activities of daily living; MRI magnetic resonance imaging; SCD subjective cognitive decline; 
CAMCOG Cambridge Cognitive Examinations; GDS Geriatric Depression Scale 
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2.1 Measures 
2.1.1 Amsterdam IADL Questionnaire (A-IADL-Q) 
The Amsterdam IADL Questionnaire (A-IADL-Q) assesses cognitively complex IADL that are prone to 
decline in incipient dementia. It covers a wide range of activities: the original version contains 70 items, 
while the short version (A-IADL-Q-SV) has 30. Both the original and short version were used in the 
included studies. We analyzed both versions, with a special focus on the short version, because all 
items from the short version are also included in the original, and can therefore be compared between 
all participants. 
 
Unlike many other IADL instruments [28], the A-IADL-Q has been extensively validated and has been 
shown to have good internal consistency, validity and reliability [29-31]. Furthermore, it appears to be 
independent of age and gender [30], and sensitive to change over time [32]. The short version was 
developed to create a more concise measure, as well as to reduce potential cultural bias by only 
including widely relevant activities [33]. International use of the A-IADL-Q is steadily increasing. All 
translations have gone through a cross-cultural adaptation process based on procedures described by 
Beaton, Bombardier [34], in which experts and prospective users were asked to evaluate the translated 
instrument (a more detailed description of this process can be found in the Supplementary Material). 
 
The questionnaire is scored using item response theory (IRT), as described elsewhere [29, 31]. IRT 
assumes that an instrument measures a latent trait, which is represented in a scale ranging from total 
absence to abundance of the particular trait [35]. The A-IADL-Q latent trait is ‘IADL functioning’ [30]. 
In IRT, parameters are calculated for each item, which contain information about item response 
category location (or difficulty, i.e., at which trait level half the population endorses a given response 
category of an item), as well as slope (or discriminatory ability, i.e., how well an item can distinguish 
between people with lower and higher levels of the trait). 
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All A-IADL-Q items have five response categories, ranging from having ‘no difficulty’ in performing an 
activity to being ‘unable to perform’ an activity due to cognitive problems. IRT-based T-scores 
representing the trait level were calibrated in a memory-clinic population and were centered around 
a mean of 50 with a standard deviation (SD) of 10. Lower scores indicate more severe functional 
impairments. 
 
2.1.2. Clinical Measures 
Mini-Mental State Examination (MMSE, scores range 0–30) [36] and Cambridge Cognition Examination 
(CAMCOG, scores range 0–107) [37] served as general indications of cognitive functioning. For both 
measures, lower scores indicate worse cognition. The Clinical Dementia Rating (CDR) [38] was an 
indicator of functional status. A global CDR score of 0 represents no dementia, and scores of 0.5 to 3 
are related to more advanced stages of dementia (and thus more functional impairment). Lastly, the 
short form Geriatric Depression Scale (GDS, scores range 0–15) [39] was used to assess depressive 
symptoms, where higher scores are indicative of more severe depressive symptoms. Data was not 
obtained for all included participants: we excluded individuals living in nursing homes (n = 130) because 
they have limited IADL independence. 
 
2.2 Statistical Analyses 
We investigated item bias using ‘differential item functioning’ (DIF) analysis. DIF analysis is a technique 
for identifying items that have different item locations and/or slopes in different groups. DIF is 
assumed to occur when the relationship between a test item and the latent trait is not the same across 
study-irrelevant groups [35]. It is considered a variation in measurement and is therefore undesirable 
[40]. We studied DIF in the following groups: (1) nationality, using the Dutch cohort as a reference 
group, while grouping all other studies by country; (2) men and women; and, based on median split, 
(3) young (< 67.2 years) and old age (≥ 67.2 years); and (4) low (< 12 years) and high education (≥ 12 
years). 
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For all DIF analyses, a minimum count of one case in at least two different response categories was 
required in each group for every item. We used the ordinal logistic regression (OLR) approach, which 
is often used and can be performed in standard software. OLR has previously been shown to be 
superior the Mantel Haenszel procedure [41]. We used the ‘lordif’ package version 0.3-3 for R, 
developed by Choi, Gibbons [40]. ‘lordif’ has been used extensively in the literature, assuring 
appropriateness and replicability of our procedures. In the OLR approach, a null model and three 
hierarchically nested models are created and compared for each item. When DIF is present and 
constant across all levels of the latent trait, it is called uniform DIF. The response categories of an item 
with uniform DIF are located at a different location in each group [42]. When an item is easier at one 
level of the trait and more difficult at another level, it is considered to have non-uniform DIF [42]. Items 
with non-uniform DIF have different discriminatory abilities in each group. Statistically significant DIF 
was determined on the basis of the likelihood-ratio chi-square test with an α level of .01, to avoid type 
I error, and because multiple nested models are being tested for each item. Because of inflated type I 
error in OLR DIF analyses [43], we added a step to establish presence of practically meaningful DIF [44, 
45], based on a McFadden’s pseudo R2 (ΔR2) value of .035 or larger. This approach reduces the risk of 
finding significant but negligible DIF, albeit at the cost of a reduction in power [43]. Furthermore, we 
used the following effect size criteria to quantify DIF size: ΔR2 values between .035 and .070 for 
moderate, and above .070 for large DIF [43]. To refine DIF detection and effect size estimates, we then 
performed Monte Carlo simulations over 1,000 replications in which the detection criteria as well as 
effect size measures are computed repeatedly over simulated data based on the empirical datasets. 
The simulated data are generated under the hypothesis that there is no DIF, while keeping the 
observed group differences in trait levels. 
 
As a means of construct validation, Pearson’s r for continuous or Kendall’s τ correlation coefficients for 
ordinal-level measures were calculated for the association between A-IADL-Q-SV T-scores and age, 
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education level, gender of the participant, cognitive functioning (MMSE and CAMCOG), functional 
state (CDR), and mood (GDS). 
 
Data were processed in SPSS Statistics version 22 [46] and R version 3.6.1 [47]. 
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3. Results 
On average, participants were 67.1 ± 9.5 (m ± SD) years old. Table 2 shows the demographics and 
clinical measures of all participants, as well as stratified by country. 
 
Table 2. Demographics and clinical characteristics for all participants, and grouped per country. 
  
  
All 
 
                
Nether-
lands Spain France 
United 
States 
United 
Kingdom Greece Serbia Finland 
Total n 3,571 1,515 1,151 509 154 93 61 45 43 
Females, n (%)1 
1,597 
(44.7) 
637 (42.0) 
485 
(42.1) 
262 
(51.5) 
104 (67.5) 43 (46.2) 18 (29.5) 25 (55.6) 23 (53.5) 
Age, years 
67.14 ± 
9.5 
63.78 ± 
8.5 
67.84 ± 
10.4 
73.48 ± 
6.2 
66.65 ± 4.5 68.42 ± 5.8 
79.99 ± 
6.4 
65.44 ± 
13.1 
71.69 ± 
2.8 
Education years 
12.19 ± 
3.9 
11.34 ± 
3.2 
11.97 ± 
4.4 
13.95 ± 
3.7 
16.82 ± 2.3 12.99 ± 3.1 9.50 ± 4.3 
13.93 ± 
4.3 
12.93 ± 
5.5 
Dementia diagnosis, 
n (%)1 
860 
(29.9) 
647 (47.2) 
188 
(20.2) 
0 (0) 0 (0) 0 (0) 21 (80.8) 4 (8.9) 0 (0) 
A-IADL-Q          
T-score2 
58.40 ± 
14.2 
51.54 ± 
11.7 
61.82 ± 
15.2 
67.33 ± 
9.4 
67.48 ± 3.5 71.16 ± 5.1 
39.48 ± 
13.9 
61.67 ± 
8.8 
66.30 ± 
5.2 
Clinical measures1          
MMSE 
26.20 ± 
4.6 
24.22 ± 
5.0 
27.76 ± 
3.7 
28.62 ± 
1.2 
29.35 ± 1.0 28.46 ± 1.5 
19.58 ± 
4.6 
27.49 ± 
3.6 
27.60 ± 
2.2 
CAMCOG 
78.57 ± 
17.3 
78.75 ± 
16.1 
80.98 ± 
19.1 
— — — 
41.62 ± 
9.7 
— — 
CDR, M (IQR) 0 (0–0.5) 0.5 (0–1) 0 (0–0) 0 (0–0) — 0 (0–0) 2 (0.5–2) — — 
GDS 3.66 ± 3.6 3.80 ± 3.3 4.09 ± 4.0 
4.33 ± 
4.2 
0.85 ± 1.3 3.52 ± 4.5 2.38 ± 3.1 — 
2.10 ± 
3.1 
All data are displayed as mean ± standard deviation, except as stated otherwise. “—” denotes that data were 
not available. 1 Data was not obtained for all participants. 2 The score shown is based on either the original or 
short version of the A-IADL-Q, as administered to each participant. 
Abbreviations: M median; IQR interquartile range; A-IADL-Q Amsterdam Instrumental Activities of Daily Living 
Questionnaire; MMSE Mini-Mental State Examination; CAMCOG Cambridge Cognitive Examinations; CDR 
Clinical Dementia Rating; GDS Geriatric Depression Scale 
 
The overall mean score on the A-IADL-Q was 58.40 ± 14.2. A-IADL-Q scores per country are shown in 
Table 2. 
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3.1 Item endorsement 
Table 3. Differences in endorsement in selected activities.  
Activity 
Country Age Gender Education 
Nether
-lands 
Spain France United 
States 
United 
King-
dom 
Greec
e 
Serbia Finlan
d 
Young Old Men Wome
n 
Low High 
Minor 
repairs 
46.2% 57.9% 67.4% 55.8% 62.4% 55.7% 57.8% 72.1% 53.6% 55.8% 70.9% 42.4% 52.8% 58.8% 
Wash-
ing ma-
chine 
58.4% 70.7% 77.0% 92.2% 75.3% 63.9% 71.1% 81.4% 72.4% 63.5% 44.0% 93.1% 65.7% 73.1% 
With-
drawing 
cash 
from 
ATM 
69.6% 64.7% 82.7% 74.0% 80.6% 9.8% 55.6% 72.1% 77.2% 62.6% 75.8% 75.4% 66.2% 82.0% 
Work-
ing 
52.3% 42.4% 54.2% 66.9% 24.7% 9.8% 53.3% 58.1% 61.6% 36.2% 53.1% 50.9% 47.4% 55.4% 
Using a 
compu-
ter 
82.0% 52.7% 75.2% 97.4% 94.6% 8.2% 53.3% 81.4% 82.1% 60.3% 79.7% 73.3% 65.3% 84.3% 
Public 
trans-
porta-
tion 
49.7% 70.5% 86.2% 27.9% 59.1% 83.6% 51.1% 79.1% 58.0% 64.5% 59.0% 66.5% 55.4% 68.0% 
Differences of interest between groups within each factor (country, age, gender, and education) are displayed 
in bold. Endorsement of other activities included in the Amsterdam IADL Questionnaire did not differ as much 
and these activities are not displayed here. 
 
Generally, item endorsement was comparable between countries, as well as between men and 
women, younger and older participants, and participants with lower and higher education. Table 3 
highlights a few activities in which there were apparent differences. ‘Minor repairs’ was endorsed by 
a larger percentage of men, as compared to women. Conversely, ‘using a washing machine’ was 
endorsed more often by women. Participants with a lower indication endorsed ‘withdrawing cash from 
an ATM’ somewhat less often than participants with a higher education. Older participants were less 
likely to work, compared to younger participants. Participants from Greece, Spain, and Serbia used 
computers less often than those from the other countries. Participants from the United States 
appeared to use public transportation less often than those from European countries (see Table 3). 
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3.2 Item bias 
 
Figure 1: DIF effect sizes for country, age, gender, and education in the A-IADL-Q-SV. 
Green circles represent the empirically found ΔR2 effect sizes; blue asterisks represent the 99th percentile ΔR2 
effect sizes from MC simulations. A solid green line is placed at the predetermined threshold for practically 
meaningful DIF (ΔR2 = .035); a dashed blue line is placed just above the highest simulated effect size threshold. 
 
Due to restricted variability in some items, we were unable to analyze all items. 272 out of 300 items 
(90.7%) in the A-IADL-Q-SV were analyzed. Of the items analyzed, 26.6% had statistically significant 
DIF. Effect sizes were very small for all factors (ΔR2 range .000–.034, see Figure 1). Monte Carlo 
simulations showed that the mean p-value for the chi-square statistic across all items varied between 
comparisons from .006 to .012, which was close to the .01 α-level used to detect DIF. Simulation-based 
thresholds for effect size ranged from .001 to .018 across all analyses (Figure 1). Lowering of the 
threshold would lead to more items being flagged for DIF. The effect sizes, however, remained very 
small. 
 
For the original version, 437 out of 490 items (89.2%) were analyzed. Of those, 20.4% had statistically 
significant DIF. The effects for age, gender and education were again small (ΔR2 range .000–.032). Four 
items showed meaningful DIF for nationality with a moderate effect. In Spain, ‘using the washing 
machine’ (ΔR2 = .043), ‘making appointments’ (ΔR2 = .064), and ‘playing card and board games’ (ΔR2 = 
.043) were flagged. All three items had uniform DIF: the first item was more difficult for Spanish 
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individuals, the other two were easier, as compared to the Dutch reference group. The fourth item had 
non-uniform DIF and was found in the French group: ‘functioning adequately at work’ (ΔR2 = .064). The 
item appeared to be better at discriminating between people with lower and higher levels of functional 
impairment in France than in the Netherlands. We used the DIF results to re-estimate the T-scores for 
Spanish and French participants, thus correcting for the effect of DIF. In the Spanish group, the mean 
score decreased by 0.16 points on the T-scale, in the French group, the mean score decreased by 0.07 
points. The largest individual differences in both countries (-1.14 and -1.33, respectively) corresponded 
to a difference of approximately one tenth of a SD, and can therefore be considered negligible. Figure 
2 shows the individual score changes after DIF correction in Spain and France. There was no meaningful 
bias for nationality in the other countries. Simulations showed the mean chi-square statistic p-value 
across all items varied from .008 to .012. The largest ΔR2 effect size was .026 (range .001–.026), which 
corresponds to a negligible effect. 
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Figure 2: Scatter plot showing the differences between initial (uncorrected) and DIF-corrected T-scores 
for the A-IADL-Q in the French (red) and Spanish (blue) groups, plotted against the uncorrected T-
scores. 
A dashed line is placed at the mean change in score in the French and Spanish groups. Difference in total score 
ranges from -0.5 to +1.5 on the T-score, corresponding to approximately one tenth of a standard deviation 
difference. A solid black line is placed at no change. 
 
3.3 A-IADL-Q-SV construct validation 
Overall, all correlations were in the same directions and of similar magnitudes as compared to the 
original validation data from the Netherlands [30]. Age seemed more strongly associated with IADL 
impairment in Spain (r = -0.47, 95%CI = [-0.51, -0.42]), Greece (r = -0.31, 95%CI = [-0.52, -0.06]), and 
Serbia (r = -0.48, 95%CI = [-0.68, -0.21]) than in the Netherlands (r = -0.08, 95%CI = [-0.13, -0.02]). 
MMSE scores appeared to be less associated with IADL impairment France (r = 0.11, 95%CI = [0.02, 
0.21]), United States (r = 0.12, 95%CI = [-0.05, 0.27]), and United Kingdom (r = -0.10, 95%CI = [-0.33, 
0.14]), compared to the reference (r = 0.33, 95%CI = [0.28, 0.38]). In these countries, the MMSE had a 
restricted score range. Conversely, MMSE scores were more strongly associated with IADL impairment 
in Serbia (r = 0.56, 95%CI = [0.32, 0.73]). An overview of all correlations can be found in the 
Supplementary Material. 
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4. Discussion 
In this study, we demonstrated that the influence of diversity on the measurement of IADL impairment, 
as measured with the A-IADL-Q, seems minimal. Although we found some differences with regard to 
activity endorsement between countries, there was no evidence of practically meaningful item bias 
caused by various factors, including age, gender, education and culture. These findings, together with 
the similar associations with demographic, cognitive and functional measures as found in earlier 
validation efforts [30], further support the validity of the A-IADL-Q. 
 
Addressing potential bias caused by various types of diversity is highly relevant in dementia research 
[14]. With respect to the measurement of functional impairment, there have been contradictory 
findings with some studies showing a general comparability of IADLs across cultures and different 
ethnoracial groups [8, 9], and others reporting differences between cultures, genders, and ages [48-
51]. For an optimal comparison of functional outcome in international studies and clinical trials, a valid, 
cross-culturally adapted instrument is crucial. In the present study, the relevance of addressing 
potential bias was underlined by the fact that we found some differences in activity endorsement, 
particularly in activities related to the household and to technology. Gender roles can differ between 
countries, and they might determine the IADL activities one participates in. In Mediterranean 
countries, it seemed people used computers less often than in Northern European countries and 
America. 
 
In our current sample, the effects of DIF were small and thus did not pass our threshold for practically 
meaningful DIF. The reason that we found little evidence of meaningful DIF may be attributed to the 
cross-cultural adaptation process that all translations went through, in which potential cross-cultural 
differences were identified beforehand and cultural adaptations were made as necessary. These 
changes were minor, and we believe the items included should be applicable to Western culture in 
general. As part of the development of the short version, international experts provided feedback on 
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the cross-cultural comparability of the items [33], which may explain the absence of practically 
meaningful item bias for nationality. Because the A-IADL-Q-SV does not appear to have practically 
meaningful item bias, T-scores do not need to be adjusted in order to be compared across countries, 
ages, genders, or levels of education. This suggests that the A-IADL-Q yields valid and cross-culturally 
comparable estimations of functional decline. Previous studies [30, 31, 33] have already shown that A-
IADL-Q scores are independent of age, gender, and education, and our findings corroborate this. This 
is an important finding, because other functional instruments do appear to be biased for gender, age, 
and cultural differences [48, 49]. 
 
In the original version, a few items appeared to be biased in Spain and France. ‘Making appointments’ 
had the largest DIF effect, and a potential explanation is that examples were added in the Spanish 
translation, because language experts indicated that the proposed translation for the word 
‘appointments’ (citas) could be interpreted as ‘(romantic) dates’, whereas the intended definition was 
broader. However, adding examples may actually have restricted the interpretation of the question to 
the specific examples given, and led to a loss of the broader meaning. The other items with DIF had a 
smaller effect, and no clear reason for the presence of DIF could be discerned. Despite the finding of 
item bias in the original version, the effect on the total scores was minimal. 
 
The associations between A-IADL-Q-SV scores and demographic, cognitive and functional measures 
we found here, largely correspond to those previously described for the original version [30]. In Spain, 
Greece, and Serbia, participants were older than average, and associations between age and IADL were 
stronger. In Spain, an association between age and IADL functioning was found earlier in a group of 
patients without dementia [21]. In France, the United States and the United Kingdom, the studies 
recruited mainly cognitively healthy participants, resulting in limited variation in the measure of 
cognition and IADL functioning seemed to be less associated with cognitive measures. 
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An important strength of this study is that we used a data-driven approach to investigate the cross-
cultural comparability of IADL. We used DIF, which is a powerful procedure to detect variance in 
measurement between groups on an item level and was possible as a result of the IRT scoring method. 
Not only does DIF tell us whether an item may be biased, but it also provides insight in the impact of 
the bias on the overall scores and it allows for correction. We additionally used simulations to further 
validate the empirical findings. These advantages allowed us to create a clear picture of possible 
measurement variance and impact on the instrument. Another strength of the study is that we 
included data from more than 3,500 individuals from eight countries. People with a wide variety of 
cognitive impairment-related diagnoses or complaints were included, ranging from subjective 
cognitive decline to dementia. Furthermore, the age of participants ranged from adulthood to old age. 
The large sample size and large variety in diagnoses and age contributes to the generalizability of our 
results and conclusions. 
 
This study also had a few limitations. First, we only included data from eight developed, Western 
countries. Our findings cannot be generalized to other parts of the world. One study found DIF in an 
IADL instrument between different Asian cultures [52]. It should also be noted that we use the term 
‘culture’ to refer to each country’s national culture. Furthermore, we did not have access to 
information about ethnicity or race. It is currently unclear what the influence of ethnoracial differences 
are on the measurement of IADL. Second, our sample was mainly comprised of highly educated people. 
The group we defined as having low education still received up to 12 years of education. It is possible 
that different results would be obtained in samples with less formal education. Third, the sample size 
was relatively small in Finland, Serbia, and Greece. This may have reduced our power to detect DIF. 
We tried to address this issue by performing Monte Carlo simulations, which indicated that the 
predetermined cutoff for practically meaningful DIF may have been somewhat high. More items would 
show DIF, if the threshold was lowered. However, when considering how these findings influence the 
total score, the impact seems minimal and the DIF effect sizes remain small. 
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The present study is an important first step in recognizing the influence of diversity on the 
measurement of functional impairment, and future studies should build on these findings. More 
research is needed to understand the differences between Western and Oriental and other cultures, 
as well as differences between ethnicities and races. 
 
The A-IADL-Q-SV might be the preferred version for future international use, as it includes only the 
most broadly relevant everyday activities, does not seem to have meaningful item bias, has good 
construct validity, and is more pragmatic. 
 
To conclude, we found no indication of the presence of clinically relevant bias caused by several 
aspects of diversity, including age, gender, education, and cultural differences. This is important, 
because it further underlines the potential of the A-IADL-Q, and the short version in particular, as an 
outcome measure of daily functioning in clinical practice and clinical trials. 
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Highlights 
 Diversity in age, gender, education and culture may influence measurement of IADL. (85) 
 3,571 people from 8 countries answered the Amsterdam IADL Questionnaire (A-IADL-Q). (85) 
 Minor item bias was found for country, with a marginal influence on total scores. (81) 
 No meaningful item bias was found for age, gender, and education. (67) 
 These findings provide evidence for valid measurement of everyday functioning. (78) 
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Supplementary Material 
Cross-cultural adaptation 
To date, the Amsterdam IADL Questionnaire has been translated into thirteen languages following an 
extensive cross-cultural adaptation process. Some translations were made by researchers who wanted 
to use the questionnaire in a language that was not yet available, while others were made on request 
by ICON plc (https://www.iconplc.com/), a company specialized in the translation of clinical 
instruments. 
 
The cross-cultural adaptation process was comprised of seven steps. First, two native speakers of the 
target language independently translated the questionnaire from either one of the two source 
languages (American English or Dutch) into the target language. Second, the two translations were 
reconciled into a single ‘forward translation’. Any discrepancies between the two translations were 
discussed and a single translation was chosen. The forward translation was subsequently translated 
back into the source language by two new individuals. This step was performed to check whether the 
intended meaning of the instructions, questions and answer options were retained. Additionally, it 
allowed the developers to review translations in languages they do not speak. If needed, adjustments 
were made in the forward translation. The fourth step was a discussion of the forward and backward 
translations among the translators, the developer and the translation project coordinator. This step 
should lead to a preliminary consensus translation (see Figure 1). 
 
 
Figure 1: Translation process for the A-IADL-Q. 
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Some activities included in the instrument were deemed to be less relevant for certain countries, e.g., 
‘preparing sandwiches’ for Spain, or ‘using the coffee maker’ for the United Kingdom. Thus, minor 
changes were made to reflect the habits in the target population better: ‘preparing sandwiches’ was 
adapted to ‘preparing a cold meal’ in Spain and ‘or making a pot of tea’ was added to ‘using the coffee 
maker’ in the United Kingdom. 
 
Subsequently, an expert committee, consisting of a small number of clinicians and knowledgeable 
professionals, was invited to review the translation for contents and clarity. The committee was asked 
to check whether the activities were clearly formulated and whether they correctly depicted the 
intended concepts. In the penultimate step, the translation project coordinator organized a pilot test 
with approximately ten caregivers to people with dementia. These caregivers should be native 
speakers of the target language and should not be experts in the field of questionnaires. In thinking-
out-loud cognitive interviews, the caregivers were asked to explain how they would interpret and 
answer the questions. 
 
In the seventh and last step, a consensus meeting was held with the translation project coordinator 
and the developer to discuss the feedback from the expert committee and cognitive interviews, and 
to address potential alterations to the translation of the items. After completion of this process, the 
translation was considered to be cross-culturally adapted and suitable for use. Translations performed 
by ICON plc were in accordance with ISO 17100:2015 regulations, and a linguistic validation certificate 
was also made available. 
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Correlations 
Table 1 
Pearson’s r or Kendall’s τ values and 95% confidence intervals for the correlations between A-IADL-Q-SV T-scores and demographic data and cognitive and 
functional measures, per country 
Country Age Education Sex. MMSE CAMCOG CDR GDS 
Netherlands1 -0.08 [-0.13, -0.02] 0.09 [0.04, 0.15] 0.04 [-0.02, 0.09] 0.33 [0.28, 0.38] 0.33 [0.28, 0.38] -0.45 [-0.49, -0.41] -0.11 [-0.16, -0.05] 
Spain -0.47 [-0.51, -0.42] 0.34 [0.28, 0.40] -0.01 [-0.08, 0.06] 0.34 [0.28, 0.40] 0.50 [0.41, 0.58] -0.13 [-0.21, -0.05] -0.04 [-0.12, 0.05] 
France 0.02 [-0.07, 0.10] 0.09 [-0.01, 0.18] -0.04 [-0.13, 0.06] 0.11 [0.02, 0.21] — -0.08 [-0.17, 0.02] -0.14 [-0.28, 0.00] 
United States 0.03 [-0.14, 0.20] 0.07 [-0.09, 0.23] -0.06 [-0.22, 0.09] 0.12 [-0.05, 0.27] — — -0.04 [-0.20, 0.12] 
United Kingdom -0.06 [-0.26, 0.15] 0.01 [-0.20, 0.21] -0.20 [-0.39, 0.00] -0.10 [-0.33, 0.14] — 0.00 [-0.24, 0.23] -0.13 [-0.33, 0.08] 
Greece -0.31 [-0.52, -0.06] 0.06 [-0.34, 0.44] -0.17 [-0.52, 0.24] 0.22 [-0.18, 0.56] 0.24 [-0.17, 0.57] -0.44 [-0.70, -0.06] 0.03 [-0.36, 0.41] 
Serbia -0.48 [-0.68, -0.21] 0.10 [-0.20, 0.38] -0.07 [-0.35, 0.23] 0.56 [0.32, 0.73] — — — 
Finland 0.01 [-0.29, 0.31] 0.12 [-0.19, 0.41] -0.15 [-0.43, 0.15] 0.31 [0.01, 0.56] — — -0.29 [-0.55, 0.02] 
1 The Netherlands served as the reference group. 
“—” denotes that data was not available. 
Abbreviations: MMSE Mini-Mental State Examination; CAMCOG Cambridge Cognitive Examinations; CDR Clinical Dementia Rating; GDS Geriatric Depression 
Scale. 
